5^th Euro Biosensors & Bioelectronics Conference June 30-01, 2016 Valencia, Spain

Dr. Kaiming Ye is a professor and chair, Department of Biomedical Engineering, Watson School of Engineering and Applied Science, Binghamton University, SUNY. Before he joined Binghamton University, he was program director for the Biomedical Engineering Program at the National Science Foundation (NSF), managing the biomedical engineering and health science funding program. His research interests focus on stem cell and regenerative medicine and 3D tissue and organ printing. He has published one book, one patent and more than 66 papers in the field. He is best known for his creative work developing 3D scaffolds for directing stem cell pancreatic differentiation, creating fluorescence nanosensors for both in vivo and in vitro continuous glucose monitoring, and formulating recombinant yeast influenza vaccines. His research has been continuously funded by NIH, NSF, JDRF, ABI and industries. He serves as executive/associate editor and editorial board member of 12 journals and has been invited to deliver keynote/plenary speeches at numerous international and national conferences. He has also served on numerous review panels and study sections for NIH and NSF. He is also program evaluator of ABET accreditation for Biomedical Engineering Programs.

Develop 3D tissue engineered scaffolds for directing lineage-specific differentiation of human embryonic and induced pluripotent stem (ES/iPS) cells into clinically-relevant cell lineages for cell replacement therapy., Build biomimetic multicellular systems for organ development and regeneration., Create fluorescent nanosensors for in vivo tracking stem cell proliferation and differentiation., Advance nanoparticle-based controlled and targeted drug delivery for cancer treatment., Develop implantable glucose sensors for continuous blood glucose monitoring in diabetic patients., Engineer fluorescence nanaosensors for real-time measurement of glucose transport in insulin-resistance tissues and cells by visualizing glucose dynamics in these cells through fluorescence lifetime imaging microscopy (FLIM) measurement.

Dr. Jang yen Wu received Ph.D from University of California. Currently he is working as an Associate Dean for Research Department of Biomedical Science at Florida Atlantic University.

Structure and Function of Neurotransmitter Enzymes and Receptors; Mechanism of Signal Transduction and Neuronal Degeneration; Neurotransmission and Neurological Disorders.

Mukesh Verma is Chief of the Epidemiology and Genomics Research Program's (EGRP) Methods and Technologies Branch (MTB), and oversees its research portfolio and initiatives that focus on methods to address epidemiologic data collection, study design and analysis, and to modify technological approaches developed in the context of other research endeavors for use as biomarkers and methods to understand cancer susceptibility. He is responsible for stimulating EGRP-funded research on epigenetic approaches in cancer epidemiology and has been instrumental in developing epigenetics research for NIH as a whole. Dr. Verma helped to develop a Request for Applications (RFA) on Environmental Influences on Epigenetics with the National Institute of Environmental Health Sciences (NIEHS) and represents the Division of Cancer Control and Population Sciences (DCCPS), in NIH's Roadmap Initiative on EpigeneticsExternal Web Site Policy. He helped develop an RFA on Comparative Systems Genetics of Cancer with NCI's Division of Cancer Biology (DCB), and is known within the extramural research community as an EGRP Program Director for Program Announcements (PAs) on Small Grants for Cancer Epidemiology and Pilot Studies in Pancreatic Cancer. He also organized a workshop to explore developing a concept for a research initiative on mitochondrial DNA and cancer epidemiology. Dr. Verma was, and continues to be, a co-Program Director for initiatives in gene-environment interactions in cancer etiology, including the Breast and Prostate Cancer and Hormone-Related Variants Cohort Consortium (BPC3), which is a collaborative project to pool data and biospecimens from a group of large prospective cancer epidemiology cohorts. Dr. Verma joined EGRP as a Program Director in 2004. In 2005, he was appointed Acting Chief of EGRP's former Analytic Epidemiology Research Branch (AERB). When EGRP reorganized in 2007, he was appointed Acting Chief of MTB and of the Host Susceptibility Factors Branch (HSFB), for which he served as Acting Chief through 2008. Before joining EGRP, he was a Program Director in NCI's Division of Cancer Prevention (DCP), where he worked in the areas of biomarkers, early detection, risk assessment, and prevention. He also was Coordinator of DCP's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. He was on the faculty in the Biochemistry Department of Georgetown University before joining NIH.

Biomarkers, Epigenetics, Epidemiology Technologies, Proteomics, MicroRNA, Methylation, Mitochondria, Nanotechnology, Risk Assessment, Susceptibility Factors, Systems Genetics, Metabolomics.

Mahmoud Almasri received PhD in Electrical Engineering from Southern Methodist University Dallas, TX, 2001. He is currently an associate professor with the Department of Electrical and Computer Engineering, University of Missouri. He was with General Monitors, CA as a research scientist. Then, he was with Albany nanotech, NY as a post doctoral research associate, and he was with Georgia Institute of Technology as a post doctoral fellow. His current research include biosensors, MEMS power harvester, IR material and detectors, MEMS Coulter counter. His research is mainly funded by NSF, ARO, LWI, and USDA. He is senior IEEE member.

Biosensors, MEMS power harvester, IR material and detectors, MEMS Coulter counter

Liviu Movileanu studied physics (1985-1990) and received a PhD in Biophysics from the University of Bucharest (1997). He held postdoctoral positions at the University of Missouri (Kansas City, Missouri, 1997-1998) and the Texas A&M University Health Science Center (College Station, Texas, 1999-2004). He is currently an Associate Professor of Physics at Syracuse University (Syracuse, New York).

His research areas include Biosensors and Functional Biomaterials, Single-molecule and Membrane Biophysics, chemical and synthetic biology, Bionanotechnology and nanomedicine, Nanofluidics, Membrane protein design.

Distinguished Professor Dr. Digvir Jayas was educated at the G.B. Pant University of Agriculture and Technology in Pantnagar, India; the University of Manitoba, and the University of Saskatchewan. Before assuming the position of Vice-President (Research and International), he held the position of Vice-President (Research) for two years and Associate Vice-President (Research) for eight years. Prior to his appointment as Associate Vice-President (Research), he was Associate Dean (Research) in the Faculty of Agricultural and Food Sciences, Department Head of Biosystems Engineering, and Interim Director of the Richardson Centre for Functional Foods and Nutraceuticals. He is a Registered Professional Engineer and a Registered Professional Agrologist.

Physical properties of agricultural products; modified atmosphere storage of grains, oilseeds, potatoes, and meats; mathematical modelling of biological systems; and digital image processing for grading and processing operations in the Agri-Food industry.

Alexander M. Seifalian (AMS) who is Professor of Nanotechnology and Regenerative Medicine and Head of Department with a multidisciplinary background from nuclear physics to physiology, nanotechnology, bio-materials, interaction of cells with nano-composite materials as well as working on stem cells. He is Fellow of the Institute of Nanotechnology (FIoN) and Society of Biology (FSB), and has published over 630 peer-reviewed articles, 41 book chapters and 10 international patents. He is currently serving as a Guest editor for Nano Reviews Journals. His current projects have led to the development of cardiovascular implants using nano-materials and stem cell technology, development of organs using tissue engineering and nano-particles for the detection and treatment of cancer. He was awarded the top prize in the field of nano-materials for cardiovascular implants in 2007 by Medical Future Innovation, and in 2009 received a Business Innovation Award from UK Trade & Investment (UKTI) in the Life Sciences and Healthcare Category. He received the most innovative new product award in 2012 for the ‘synthetic trachea’ by European Life Science, Hamburg, Germany, and in 2013 was acknowledged by the international community for his outstanding achievements in Nano-science and Nanotechnology with the prestigious Nanosmat prize award in Granada, Spain. AMS has a significant track record with regard to generating impact through the translation of technology from the laboratory directly to the clinic, and has demonstrated that nano composite polymers are core to the next generation of surgical implants with highly successful outcomes in a number of pioneering projects. This led to the development of the world’s first synthetic trachea, nasal and ear reconstruction, lacrimal duct conduit, and small diameter bypass grafts for coronary artery and vascular replacemnet, which has enter clinical trials, all of which have been used as first-in-man. His experience in translational research has led to a number of cutting edge projects at various stages of development. For example, we have developed abdominal aortic aneurysm (AAA) stent-grafts, cardiac patches and transcatheter heart valves at the pre-clinical stage of development and will be ready for clinical trials in early 2015.

His research team is highly experienced in reaching planned objectives and delivery of projects of this nature. During his career he has led many large projects with multidisciplinary teams composed of scientists, engineers, and clinicians in collaboration with UK industry, all with very successful outcomes in terms of commercialization and translation to benefit patient healthcare including; i) commercialization of bypass grafts for vascular access and dialysis; and ii) development of laser activated vascular sealants, which have been commercialized, and many others medical devices currently in development

Dr. Jonghwa Kim completed his PhD in 2003 from Technical University Berlin. Until then, he completed his Diploma, MSc. and BSc. from Technical University, Kyungwon University respectively. Finally he obtained his Habilitation in computer science from University of Augsburg, Germany.He served as the visiting Professor at National Institute of Informatics (NII), Tokyo, Japan in 2006. Presently he is serving as an Associate Professor at University of Augsburg, Germany. He was also awarded Young-Scholar-Fellowship during his Doctrate. He has published a no. of articles as well as Books and editorials.

Intelligent digital signal processing, Human-computer interface, emotion recognition, Biomedical signal processing, Bio-inspired interface, Parametric pattern classification, Music information retrieval, Multisensory data fusion, Affective human-robot interface, Home-healthcare application.

Mari Carmen Horrillo Güemes received her PhD in chemistry from the University Complutense of Madrid in 1992. From 1993 to 1995 she was working at the Institute for Advanced Materials of the European Commission's Joint Research Centre (Ispra, Italy). Since then she is a full time senior researcher at the CSIC, at this moment in the Instituto de Tecnologías Físicas y de la Información (ITEFI), and she is working on R&D of bio and chemical microsensors and electronic noses for environmental protection, quality control of foods and security. She is author of over 100 publications in Journals of high impact index, and she has three patents in her field. She was member of the Scientific Advisory Committee of the CSIC (2005-2008). She was head of the department of Gas and Surface technologies from 1999 to 2011

Sensors, Actuators, Chemosensors.

1979 Visiting graduate student, Imperial College. 1977-1984 Assistant, UOP. 1984-1998 Lecturer, UOP. 1988-1994 Member of Technical Committee TE35 of Greek Standardization Office (Solar Energy National Standards). 1992 National Representative of Technical Committee ISO for Solar Energy. 1992-1994 Technical Expert for Car repair and Maintenance, Responsible for Design-Assessment of training modules (Euro qualification-EUROFORM). 1994-1996 Visiting Professor, Washington University, St. Louis, Missouri, U.S.A. 1994-now Design-Development of Mechanical-Biomedical Systems. 1998-2002 Assistant Professor, UOP. 2003- now, Associate Professor, UOP. 2007-2009 Construction Division Director, DMEA, UOP. 2009-now Health-Safety Committee member, UOP. 2009-now Collaboration between Johns Hopkins and UOP, committee member. 2003-now Hellenic NARIC, Academic Consultant.) 2000-2001 and 2010-2011 DMEA. Senate elected-representative, UOP. Greek Engineers Technical Chamber and Courts, technical expert. Conference Scientific-Organizing Committees member.

Dynamic behavior of thermo mechanical continua, Design of mechanical and biomedical systems, Product design, Development of analytical and experimental methodology for assessment of structural integrity, Development of assessment tool for mandible bone quality, Rotating dental tools, Assessment of mechanical properties of the prostate gland, Mapping of vagina stiffness, Cartilage structural integrity, Bone fracture healing, Structural integrity assessment of fibrocartilage meniscus tissue.

Prof. Ruey-an Doong earned his Ph.D. degree in Environmental Engineering from the National Taiwan University, Taiwan in 1992. He joined the Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan in 1994. He served as the Department Head in 2008 and Dean of the College of Nuclear Science, National Tsing Hua University in 2011. Currently, he is a full professor in the Institute of Environmental Engineering, National Chiao Tung University, Taiwan. His research interest lies in the areas of environmental chemistry and environmental nanotechnology.

environmental chemistry and environmental nanotechnology.

Lucian Baia earned his Ph.D. degree in 2003 at the University of Würzburg, Germany. Since 2008, he works as Associate Professor at the Department of Condensed Matter Physics and Advanced Technologies at the Faculty of Physics of the Babes-Bolyai University. His current research focuses on the obtaining and characterization of porous and highly porous Nano architectures with controllable morphology and structure for environmental and biomedical applications. He is author or coauthor of more than 100 peer-reviewed publications (h-index: 19), three books, and three book chapters, 3 patent applications and is serving as editorial board member for several scientific journals as follows: ISRN Nanotechnology, Journal of Material Science & Technology Research, Journal of Biosensors & Bioelectronics, Journal of Electrical & Electronics and International Journal of Global Advancements in Material science & Nanotech.

Synthesis of porous and highly porous nano-architectures with controllable morphology and structure for biomedical and environmental applications and their characterization by Raman, IR, UV-vis and SERS spectroscopic techniques as well as XRD, TEM and N2 adsorption/desorption measurements. Ö¾ Structural analyses of undoped and transition metal oxides doped glasses and glass-ceramics with special physical properties by means of complementary techniques.